ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1035

Psoriatic Arthritis and Mortality – a Nationwide Study

Thorvardur Jon Love1,2, Thor Aspelund3, Alexis Ogdie4, Joel M. Gelfand5, Hyon K. Choi6, Vilmundur Gudnason3 and Bjorn Gudbjornsson2, 1Landspitali University Hospital, Reykjavik, Iceland, 2Faculty of Medicine, University of Iceland, Reykjavik, Iceland, 3The Icelandic Heart Association, Kopavogur, Iceland, 4Rheumatology and Epidemiology, University of Pennsylvania, Philadelphia, PA, 5University of Pennsylvania., Philadelphia, PA, 6Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: death, population studies and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services II & III

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Psoriatic arthritis is an inflammatory arthritis that causes significant morbidity. While a study from a single research clinic in Canada published in the 1990´s suggested an increased mortality rate compared to that seen in the general population, two recent studies from the UK reported no increased mortality, one based on a single center similar to the Canadian study, and the other based on a sample from the general population. We have performed a study of the mortality rate among all known cases of psoriatic arthritis diagnosed since 1971 in Iceland compared to the general population of the same country.

Methods:

We used a list of all known patients in Iceland with a diagnosis of psoriatic arthritis assembled in 2002-2003 for a cross-sectional study of psoriatic arthritis in Iceland. The list includes both those patients who were still alive in 2002, as well as those who had died before the study began. This list has been validated by examining close to 200 patients, showing that about 85% had active disease in 2003 and more than 80% fulfilled the CASPAR criteria applied post-hoc. Using national identification numbers and the Icelandic national mortality database we were able to determine the year of death for all individuals who died before end of year 2012, making death ascertainment complete. Using data on age- and sex stratified 1-year survival for the Icelandic population available for each year starting in 1971 we were able to compare the survival of patients with psoriatic arthritis to the expected survival of the age- and sex-matched population starting the year that each psoriatic arthritis diagnosis was made.

Results:

The list of psoriatic arthritis patients contained 346 individuals and data on the date of diagnosis of psoriatic arthritis was available for 340. Of these, 293 were diagnosed in 1971 or later and could be used for comparison to the population statistics, with 6747 patient years of follow-up. The mean age at the time of diagnosis was 42.3 years (95%CI 40.1 – 44.4), with 57 diagnosed in the 1970´s, 98 diagnosed in the 1980‘s, 137 diagnosed in the 1990´s and 1 diagnosed in 2001. This is equivalent to an incidence rate of 3.8 (2.9 – 5.0), 5.7 (4.6 – 7.0), and 7.2 (6.1 – 8.6) incident cases per year per 100.000 individuals age 18 or older for each of the three whole decades included in the study.

Out of 107 men with psoriatic arthritis, 28 had died by the end of 2012, and the same was true for 42 of 186 women with psoriatic arthritis. The age- and sex-specific expected number of deaths updated annually based on year of diagnosis was 27 men and 39 women. The age- and sex-standardized mortality ratio of psoriatic arthritis patients compared to the general population was 1.06 (95% CI 0.84-1.13), p=0.64.

Conclusion:

There was no increased death rate among psoriatic arthritis patients compared to the general population.


Disclosure:

T. J. Love,
None;

T. Aspelund,
None;

A. Ogdie,
None;

J. M. Gelfand,
None;

H. K. Choi,
None;

V. Gudnason,
None;

B. Gudbjornsson,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/psoriatic-arthritis-and-mortality-a-nationwide-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology